[Toward Personalized Cancer Therapy with Oral Molecular-targeted Agents].

We examined the relationship between the plasma concentration of drugs and clinical findings, such as side effects and treatment effects, at our hospital. In this symposium review, we introduce our results based on the treatment of patients with renal cell carcinoma.
PMID: 31155535 [PubMed - in process]

Source: Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan - June 4, 2019 Category: Drugs & Pharmacology Authors: Yamaguchi H, Takasaki S, Kikuchi M, Kawasaki Y, Arai Y, Mano N Tags: Yakugaku Zasshi Source Type: research